Temporary USMLE Step 3 Eligibility Requirements Are in Effect

Last month, the United States Medical Licensing Examination® (USMLE®) program announced temporary USMLE Step 3 eligibility requirements during the suspension of the USMLE Step 2 Clinical Skills (CS) examination. The temporary eligibility requirements, applicable to examinees who have not yet passed the Step 2 CS, are in effect within the Step 3 registration system starting Sept. 3, 2020 at 1 p.m. U.S. Central Time.

Examinees should read the full announcement on the USMLE website.

COVID-19 Update for the USMLE Program

Delayed Change to USMLE Attempt Limit Policy

In February 2020, the United States Medical Licensing Examination® (USMLE®) program announced a reduction in the allowable number of exam attempts on each Step or Step Component from six to four that would go into effect no earlier than January 1, 2021. Due to the reduced testing capacity caused by COVID-19 (Coronavirus), the USMLE program is delaying the implementation of this policy change to no earlier than July 1, 2021.

Step 2 Clinical Skills (CS) Refunds

Last week, NBME and ECFMG sent e-mails to examinees who were registered to take Step 2 CS and were unable to test due to suspension of the exam. These e-mails included information about the refund process and timeline.

Prometric

As the USMLE program continues its plans to expand USMLE testing, Prometric states that their testing capacity continues to increase as well. Since May 1, more than 21,000 USMLE examinees have tested. For examinees looking to secure a Prometric appointment, please continue to check the Prometric website for updated information, site openings/closings, and available appointments.

Examinees should continue to monitor the USMLE COVID-19 Resource Center, the USMLE website, and USMLE social media for updates.

USMLE COVID-19 Update: A Phased Approach for Expanding Step 1, Step 2 CK, and Step 3 Testing

On May 15, the United States Medical Licensing Examination® (USMLE®) program published a weekly COVID-19 update on its website. Topics include:

  • Expanding Testing Capacity for Step 1, Step 2 CK, and Step 3
  • Delaying Step 1 and Step 2 CK Content Changes

Examinees should read the full announcement on the USMLE website.

On May 18, the the USMLE program published an announcement that a pilot will begin next week for phase one of the approach for expanding testing capacity: regional testing centers at U.S. medical schools.

On May 20, the USMLE program published an update on regional and event-based testing at U.S. medical schools.

Examinees should monitor the USMLE website frequently for updates.

(posted May 20, 2020; updated May 21, 2020)

USMLE Update on Resuming Testing

Resuming United States Medical Licensing Examination (USMLE®) testing remains the USMLE program’s top priority. Below, please read several key updates.

Status of Prometric Testing
Testing resumed at select Prometric centers on Friday, May 1 in accordance with state and local social distancing guidelines. Although hundreds of examinees successfully tested, the overall examinee experience is not meeting expectations. The USMLE program continues to exert pressure on Prometric to rectify all issues in a timely manner. The USMLE program is working daily with Prometric and they have dedicated resources to both resume USMLE testing and address the quality of the examinee experience.

The USMLE program understands that when Prometric test centers reopened, some examinees with confirmed slots traveled to test centers only to find them closed, leading to increased confusion during an already difficult situation. The USMLE program has been disappointed with Prometric’s failure to fulfill its obligations to examinees and to the USMLE program. The USMLE program has emphasized to Prometric the importance of their obligations to examinees and the harm that their failures have caused.

Examinees who have suffered direct out-of-pocket monetary losses due to Prometric’s lack of communication or miscommunication regarding test center closures should submit a written claim directly to Prometric at prometric.com/contact-us.

In March 2020, in response to the suspension in testing, the USMLE program extended eligibility periods to December 2020 for all examinees who had a Step 1, Step 2 Clinical Knowledge (CK), or Step 3 scheduling permit with an unexpired eligibility period with an end date in 2020. To help alleviate some of the pressure examinees may be feeling, USMLE will further extend eligibility periods through June 2021.

  • Note: Eligibility period extensions will be processed approximately over the next eight to twelve weeks.

Alternate Delivery of USMLE Step 1, Step 2 CK, and Step 3
To resume testing, the USMLE program has already identified several options for proctored testing outside of Prometric centers. The USMLE program is expecting to begin testing at some medical school campuses this month. USMLE is committed to offering a broader distribution of testing at medical schools; it is working through technological challenges in order to do so. While this solution will not completely address the testing backlog, it will provide additional USMLE-specified slots within Prometric’s overall capacity, which is increasing. Schools are being considered based on geographic location and a willingness to serve as a regional testing site. Because the USMLE program is not able to scale this solution to all schools, it plans to deliver other solutions as well. The USMLE program will ramp-up testing as we institute new systems and processes.

The USMLE program continues to aggressively explore remote proctoring and expects to have progress to report on the timeline for that project in the next week.

Validity, Reliability, and Fairness
The USMLE program recognizes the burden that reduced testing capacity places on schools and examinees. As the USMLE program moves forward with solutions to alleviate this burden, it must also evaluate the fairness of any test administration method. The USMLE program needs to ensure that its test administration models allow all test takers to reliably and validly demonstrate their skills and maximize, to the extent possible, fairness, access, security, and reliability. Increasing capacity by deploying exam administrations to schools may create differential geographic access. Similarly, with respect to remote proctoring, the USMLE program recognizes that not all schools or individuals have equal access to high-speed internet, a computer that meets the technology requirements for remote proctoring, or dedicated space in which to take the test.

Given these issues of fairness and bias, the USMLE program will continue to work with organizations in the medical education and the medical regulatory community to identify temporary changes to policy and requirements such as relaxing requirements for promotion, graduation, or licensing decisions. The USMLE program is committed to continuing its focus on delivering safe testing and fair test results for examinees.

Step 2 CS
As announced previously, Step 2 Clinical Skills (CS) testing has been suspended due to the COVID-19 (coronavirus) pandemic, and the USMLE program is pursuing testing solutions to ensure the health and safety of examinees and test center staff. After careful consideration, the USMLE program has determined that it cannot resume the exam in its current format without unacceptable risk to examinees and staff.

Prior to COVID-19, the USMLE program was in the very early stages of exploring alternate formats and methods for delivery of the Step 2 CS exam, as part of overall efforts to enhance the USMLE. As a result of COVID-19, these plans have been accelerated and are focused on a testing solution that employs a telehealth model, where examinees and standardized patients would interact on-line, via a web browser. The USMLE program is aggressively assessing this solution, which will require significant redesign of the exam’s content and delivery. Expediting such changes to the exam format and delivery will help result in a safe and effective assessment for all involved.

At this time, Step 2 CS testing is expected to resume after July.

Please know that the USMLE program is doing everything it can to address the challenges of this new environment quickly, and that it will continue to provide you with updates on its progress.

A Message from the Leaders of NBME and ECFMG|FAIMER

Dear International Medical School Educators, Students, and Graduates:

We recognize that the disruptions to USMLE testing present an extraordinary challenge for all of you. Finding a means to restore USMLE testing is a top organizational priority. Our goal is to collaborate with you as we determine how to assure rapid and safe resumption of testing across a variety of venues. We recognize the impact on both U.S. domestic students as well as those of you in our international community.

Status on Prometric Testing

We are receiving reports that several Prometric test centers are erroneously listed as open, and some examinees with confirmed slots were met with closed centers when Prometric resumed limited testing on May 1st. This has led to a confusing and difficult situation for examinees. We are deeply disturbed by the experience you may be having and are working to immediately find resolution to these issues.

Prometric CEO, Roy Simrell, is aware of our shared dissatisfaction with the current situation and the need for a clear and immediate plan to rectify the problems experienced by examinees. We have been, and continue to be, in daily contact with Prometric to represent the needs of the examinees and faculty to improve the execution of the safe resumption of testing and Prometric’s communication with examinees. We have emphasized the impact their actions have on this critical community and the need to ensure examinees are provided timely and reliable information.

We expect capacity constraints and challenges to continue. For this reason, we are working hard to design and deliver solutions even outside of Prometric test centers.

Alternate Delivery of USMLE Step 1, Step 2 CK, and Step 3

We have several efforts underway to resume testing and to address testing backlog and capacity constraints. We have incorporated the suggestions and ideas we have received from medical students, medical school faculty, state medical boards, and our international partners in this work, and will seek to partner even more closely as we move forward with implementation. We expect to have better insight on feasible alternatives and associated requirements within the next week. We will continue to provide at least weekly updates of our progress at usmle.org and ecfmg.org.

Step 2 CS

We are dedicated to finding a testing solution for Step 2 CS that assures the safety of examinees and standardized patients as our top priority. We have a dedicated team exploring innovative and disruptive solutions to resume Step 2 CS examinations. This includes options that alleviate the need to travel to examination centers. We expect to have more news next week.

Partnership

Working together, we can respond to the challenges wrought by the COVID pandemic and ensure the continued excellence of America’s future physicians.

Peter J. Katsufrakis, M.D., M.B.A.
President and CEO, National Board of Medical Examiners
William W. Pinsky, M.D., FAAP, FACC
President and CEO, ECFMG|FAIMER
Chair, Board of Trustees, FAIMER
Professor (Hon.), University of Queensland

Status on Prometric Testing – May 1, 2020

The USMLE program is aware that several Prometric test centers are erroneously listed as open, so some examinees with confirmed slots were met with closed centers when Prometric resumed limited testing on May 1st. This has led to increased confusion during an already difficult situation for examinees. The USMLE program is working to immediately find resolution to these issues.

The USMLE program has been and continues to be in daily contact with Prometric to represent the needs of the examinees and stakeholders to improve the safe resumption of testing and Prometric’s communication with examinees. On May 1, USMLE program senior leaders met with Prometric to share their dissatisfaction with the current situation and the need for a clear and immediate plan. The USMLE program emphasized the impact their actions have had on this critical community and the importance of providing examinees with timely and reliable information.

The USMLE program expects capacity constraints and challenges to continue. For this reason, as previously announced, the USMLE program is  working hard to accelerate alternate test delivery solutions.

For more information on the impacts of the COVID-19 pandemic on ECFMG|FAIMER programs and what we are doing in response, please visit our COVID-19 (Coronavirus) web page.

USMLE Exploring Alternate Test Delivery Options

Finding safe solutions to accommodate examinees’ testing needs has been the United States Medical Licensing Examination® (USMLE®) program’s main focus and highest priority over the past few months. Due to increasing uncertainty around having wider availability of in-person testing at Prometric test centers, the USMLE program has identified several alternate test delivery methods for Step 1, Step 2 CK, and Step 3 and has begun aggressively pursuing them.

Examinees should read the full announcement on the USMLE website.

For more information on the impacts of the COVID-19 pandemic on ECFMG|FAIMER programs and what we are doing in response, please visit our COVID-19 (Coronavirus) web page.

Updated Prometric Procedures

Prometric announced their extended closure of test centers until May 31, 2020 with the exception of a limited set of essential services programs. The United States Medical Licensing Examination® (USMLE®) is considered an essential program, and certain centers will still be able to resume testing in accordance with local social distancing guidelines on May 1, 2020. More information about Prometric’s updated procedures, including enhanced test center measures, can be found on their website.

To conform with social distancing guidelines and keep separation between examinees, there will be a reduction of active workstations in Prometric testing rooms. To do this, Prometric plans to cancel a significant number of upcoming scheduled appointments. Their statement explains that random selection of canceled appointments will occur, and impacted candidates will be notified by Prometric starting today.

Prometric plans to expand testing capacity through increased test center hours and days of operation. Please keep checking their website for updates, and the USMLE program will continue to share new information.

The USMLE program extended eligibility periods to December 2020 for all examinees who had a USMLE Step 1, Step 2 CK, Step 3, or USMLE Practice Session scheduling permit with an unexpired eligibility period with an end date in 2020, regardless of the country in which they are testing. The USMLE program will continue this process for any newly issued scheduling permits. Eligibility periods will be extended automatically, requiring no action from examinees.

The USMLE program recognizes the stress and uncertainty of this situation as many assessment programs are impacted by the backlog of examinees and the reduction of testing capacity at Prometric centers. They are actively working with the medical education and regulation community to mitigate the impact of testing disruption for U.S. and international medical students and graduates.

USMLE’s Weekly Update on COVID-19

The United States Medical Licensing Examination® (USMLE®) program recognizes that the testing shutdown has created great stress, uncertainty, and disruption for examinees and medical schools, affecting academic progression, curricular schedules, and application for residency. The USMLE program is doing everything it can to make decisions that prioritize the safety and health of examinees and test center staff as they develop plans to resume testing.

Beginning April 17, 2020, the USMLE program will post weekly updates on its website and social media channels, in addition to announcements, as soon as decisions are finalized.

Examinees can read the full announcement on the USMLE website and should continue to monitor the USMLE website weekly for the latest update. As always, the USMLE program will update its FAQs regarding USMLE and COVID-19 (Coronavirus) as frequently as possible.

COVID-19 (Coronavirus) 4/10/2020 Update: Prometric Closures and Step 1, Step 2 CK, and Step 3

Prometric announced on April 10 that test centers in the United States and Canada will remain closed until May 1, 2020.

In response to the previously announced closures, the United States Medical Licensing Examination® (USMLE®) program extended eligibility periods to December 2020 for all examinees who had a USMLE Step 1, Step 2 CK, Step 3, or USMLE Practice Session scheduling permit with an unexpired eligibility period with an end date in 2020, regardless of the country in which they are testing.

The USMLE program will continue this process for any newly issued scheduling permits. Eligibility periods will be extended automatically, requiring no action from examinees.

Extending the eligibility period for your Step 1, Step 2 CK, Step 3, or USMLE Practice Session examination will not impact already scheduled appointments. No fees will be charged for these eligibility extensions.

Please continue to check the USMLE website and social media for updates.

If you are scheduled to take a USMLE examination in a region outside the United States and Canada, please check the Prometric website for the most current list of test center closures before going to the test center on your scheduled test day.

Thank you for your patience, cooperation, and understanding during this challenging time.

For more information on the impacts of the COVID-19 pandemic on ECFMG|FAIMER programs and what we are doing in response, please visit our COVID-19 (Coronavirus) web page.

(posted March 17, updated March 20; March 28; April 1, April 13)